EUVIMEDEUVIMED entdecken
Crossref

Computational Screening of Anticancer Phytochemicals From IMPPAT2.0 Database: Molecular Docking and Molecular Dynamics Evaluation Against EGFR and FGFR3

Zohra Siddiqui, Anushree Maurya, Mamta Pal, Raj Shukla, Vansh Sinha, Ruchi Srivastava, Shilendra K. Pathak, Vikas K. Shukla, Onkar Prasad, Leena Sinha

ChemistrySelect · 2026-09 · 11 (34)

DOI: 10.1002/slct.74349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 02.09.2026. Verfasst von Zohra Siddiqui und 9 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EGFR and FGFR3 are receptor tyrosine kinases that regulate cell growth and survival, and their dysregulation contributes to cancer progression. In this study, phytochemicals from the IMPPAT 2.0 database were screened in silico using FDA‐approved anticancer drugs as reference molecules, followed by evaluation against EGFR and FGFR3. The workflow included ligand‐based virtual screening, drug‐likeness assessment, toxicity prediction, DFT optimization, molecular docking, molecular dynamics simulations, and ADMET profiling. Four candidates–‐IMPHY005097, IMPHY005655, IMPHY014154, and IMPHY017537–‐were shortlisted based on drug‐likeness and safety filters. Their geometries were optimized and docked against EGFR (PDB: 6JZ0, 4JQ7) and FGFR3 (PDB: 6LVM, 7DHL). Among the four compounds, IMPHY005655 showed the strongest binding to both targets and a higher predicted affinity toward 7DHL than its native ligand, while maintaining comparable affinity in EGFR complexes. Electronic properties were evaluated at the DFT/B3LYP/6‐311++G(d,p) level. MD simulations (200 ns) of 6JZ0‐IMPHY005655 and 7DHL‐IMPHY005655 supported stable complex formation, based on RMSD, RMSF, hydrogen bonding, radius of gyration, and SASA trends. Comparison with the native ligands (CKO and H6X) showed that IMPHY005655 exhibits improved drug‐likeness along with more favorable pharmacokinetic and toxicity predictions. These findings identify IMPHY005655 as a promising computational lead with potential dual EGFR/FGFR3 targeting and support further experimental validation.

Zitieren

APA

Siddiqui, Z., Maurya, A., Pal, M., Shukla, R., Sinha, V., Srivastava, R., Pathak, S. K., Shukla, V. K., Prasad, O., & Sinha, L. (2026). Computational Screening of Anticancer Phytochemicals From IMPPAT2.0 Database: Molecular Docking and Molecular Dynamics Evaluation Against EGFR and FGFR3. ChemistrySelect, 11(34). https://doi.org/10.1002/slct.74349

Vancouver

Siddiqui Z, Maurya A, Pal M, Shukla R, Sinha V, Srivastava R, et al. Computational Screening of Anticancer Phytochemicals From IMPPAT2.0 Database: Molecular Docking and Molecular Dynamics Evaluation Against EGFR and FGFR3. ChemistrySelect. 2026;11(34). doi:10.1002/slct.74349

BibTeX
@article{Siddiqui2026,
  author = {Siddiqui, Zohra and Maurya, Anushree and Pal, Mamta and Shukla, Raj and Sinha, Vansh and Srivastava, Ruchi and Pathak, Shilendra K. and Shukla, Vikas K. and Prasad, Onkar and Sinha, Leena},
  title = {Computational Screening of Anticancer Phytochemicals From IMPPAT2.0 Database: Molecular Docking and Molecular Dynamics Evaluation Against EGFR and FGFR3},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {34},
  doi = {10.1002/slct.74349}
}
Kostenlos starten →